Article thumbnail

Impact of the tissue factor pathway inhibitor gene on apoptosis in human vascular smooth muscle cells

By Xia Dong, Li-ping Song, Dun-wan Zhu, Hai-ling Zhang, Lan-xia Liu and Xi-gang Leng


Tissue factor pathway inhibitor (TFPI) plays a vitally important role in the blood coagulation pathway. Recent studies indicated that TFPI induces apoptosis in vascular smooth-muscle cells (VSMCs) in animals. The present study investigated whether the TFPI gene could also induce apoptosis in human vascular smooth-muscle cells (hVSMCs). Such cells were isolated from human umbilical arteries and subsequently transfected with pIRES-TFPI plasmid (2 μg/mL). MTT assaying and cell counting were applied to measure cell viability and proliferation, RT-PCR was utilized to analyze TFPI gene expression in the cells. Apoptosis was analyzed by fluorescence activated cell sorting (FACS). Several key proteins involved in apoptosis were examined through Western blotting. It was shown that TFPI gene transfer led to its increased cellular expression, with a subsequent reduction in hVSMC proliferation. Further investigation demonstrated that TFPI gene expression resulted in lesser amounts of procaspase-3, procaspase-8 and procascase-9, and an increased release of mitochondrial cytochrome c (cyt-c) into cytoplasm, thereby implying the involvement of both extrinsic and intrinsic pathways in TFPI gene-induced apoptosis in hVSMCs

Topics: Human and Medical Genetics
Publisher: Sociedade Brasileira de Genética
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). Adenovirus-mediated gene transfer of tissue factor pathway inhibitor induces apoptosis in vascular smooth muscle cells.
  2. (2004). Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes.
  3. (2003). Biological characteristics of human umbilical artery smooth muscle cells cultured in vitro and the preestablishment of immortalized cell line. Sichuan Da Xue Xue Bao Yi Xue Ban
  4. (2001). Cellular responses to DNA damage.
  5. (1998). Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells.
  6. (2004). Factors inducing in-stent restenosis: An in-vitro model.
  7. (1997). Funatsu A
  8. (1993). Human neonatal and adult vascular smooth muscle cells in culture. Exp Mol Pathol 58:25-39.
  9. (1998). Human recombinant tissue factor pathway inhibitor inducesapoptosisinculturedhumanendothelialcells.FEBS
  10. (2002). Immune escape of tumors: Apoptosis resistance and tumor counterattack.
  11. Kamikubo Y and SumiyoshiA(1997)Tissuefactorpathwayinhibitorinhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
  12. Liu B and KentKC(2000)Theeffectofgrowthfactors,cytokines,and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells.
  13. PuppinckPandLartigauE(2003)Hyperplasiaofthearterial intimaduetosmoothmusclecellproliferation.Currentdata, experimental treatments and perspectives.
  14. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.
  15. (1990). Regulation of coagulation by a multivalent Kunitz-type inhibitor.
  16. (1999). Sumiyoshi A
  17. (1999). Takeshita A and Yasui H
  18. (2008). TFPI induces apoptosis in hVSMCs 29Kiernan TJ,
  19. (1999). The apoptosome: Heart and soul of the cell death machine. Neoplasia 1:5-15. DelGiudiceLAandWhiteGA(2009)Theroleoftissuefactorand tissue factor pathway inhibitor in health and disease states.
  20. (2000). The mechanisms of coronary restenosis: Insights from experimental models.
  21. (2001). Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low densitylipoproteinreceptor.JBiolChem276:12241-12248.
  22. (2004). Toxic proteins released from mitochondria in cell death.